Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group (Q70955349)
Jump to navigation
Jump to search
scientific article published on 01 November 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group |
scientific article published on 01 November 1995 |
Statements
Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group (English)
R Lin
E Roach
M Zimmerman
S Strasser
1 November 1995